CRIS Current Research Information System

ERCOLANI, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.514
AS - Asia 17.221
EU - Europa 15.502
AF - Africa 1.278
SA - Sud America 1.242
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 9
Totale 57.800
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.299
SG - Singapore 5.748
CN - Cina 4.862
IT - Italia 3.356
GB - Regno Unito 3.349
VN - Vietnam 3.088
DE - Germania 2.079
SE - Svezia 1.653
HK - Hong Kong 1.438
BR - Brasile 928
IN - India 881
RU - Federazione Russa 856
NL - Olanda 764
IE - Irlanda 633
FR - Francia 631
UA - Ucraina 591
KR - Corea 441
CI - Costa d'Avorio 352
CH - Svizzera 345
ZA - Sudafrica 327
FI - Finlandia 321
TG - Togo 260
EE - Estonia 255
JP - Giappone 195
BG - Bulgaria 174
SC - Seychelles 157
AR - Argentina 138
AT - Austria 136
JO - Giordania 133
CA - Canada 124
ID - Indonesia 104
NG - Nigeria 96
BE - Belgio 67
MX - Messico 64
PL - Polonia 62
EC - Ecuador 58
ES - Italia 51
BD - Bangladesh 44
TR - Turchia 41
IR - Iran 38
AU - Australia 28
CL - Cile 26
HR - Croazia 25
PK - Pakistan 24
PY - Paraguay 24
GR - Grecia 23
PE - Perù 23
RO - Romania 23
LB - Libano 21
LT - Lituania 21
CO - Colombia 20
MA - Marocco 19
MY - Malesia 19
PH - Filippine 18
AE - Emirati Arabi Uniti 16
IQ - Iraq 16
UZ - Uzbekistan 16
IL - Israele 14
VE - Venezuela 14
PT - Portogallo 13
EG - Egitto 12
ET - Etiopia 10
MK - Macedonia 9
SA - Arabia Saudita 9
AZ - Azerbaigian 8
CZ - Repubblica Ceca 8
KE - Kenya 8
LU - Lussemburgo 7
TN - Tunisia 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
KZ - Kazakistan 6
RS - Serbia 6
TW - Taiwan 6
BA - Bosnia-Erzegovina 5
DK - Danimarca 5
DZ - Algeria 5
KH - Cambogia 5
LI - Liechtenstein 5
NZ - Nuova Zelanda 5
SN - Senegal 5
EU - Europa 4
HU - Ungheria 4
NO - Norvegia 4
PA - Panama 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
BY - Bielorussia 3
CR - Costa Rica 3
GH - Ghana 3
JM - Giamaica 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
MG - Madagascar 3
MM - Myanmar 3
NP - Nepal 3
TH - Thailandia 3
Totale 57.749
Salva come PNG Salva come JPEG
Città #
Singapore 3.736
Southend 2.958
Fairfield 2.820
Ashburn 2.451
Chandler 1.662
Hong Kong 1.429
Dong Ket 1.321
Woodbridge 1.236
Wilmington 1.111
Santa Clara 1.043
Hefei 1.023
Seattle 1.003
Houston 960
Cambridge 866
Princeton 785
Beijing 671
Ann Arbor 652
Boardman 588
Dublin 579
Bologna 494
Ho Chi Minh City 447
Seoul 431
Dallas 354
Abidjan 352
Los Angeles 341
Munich 334
Jacksonville 329
Westminster 316
Nanjing 303
Milan 295
Hanoi 289
Padova 264
Lomé 260
Berlin 235
Helsinki 233
New York 212
Bern 201
Buffalo 197
Florence 193
Tokyo 183
San Diego 171
Sofia 166
Jinan 164
Shenyang 152
Saint Petersburg 149
Redmond 139
Redondo Beach 139
Amman 132
Frankfurt am Main 118
Turin 114
Menlo Park 112
Bengaluru 102
São Paulo 102
Rome 101
Changsha 100
Guangzhou 100
Shanghai 94
Dearborn 93
Nanchang 93
Hebei 89
Abeokuta 80
Chicago 80
Vienna 80
Jiaxing 78
Tianjin 74
Mülheim 73
Medford 71
Des Moines 69
Nuremberg 69
Falkenstein 64
Brussels 61
Zhengzhou 57
London 56
Amsterdam 55
Olalla 55
Haiphong 54
Hangzhou 52
Jakarta 52
Toronto 49
Falls Church 48
Redwood City 47
Norwalk 46
Phoenix 46
Yubileyny 44
Bremen 43
Ningbo 42
Paris 41
Turku 41
Warsaw 40
Brooklyn 39
Haikou 39
Bühl 38
Da Nang 38
Verona 36
Taiyuan 35
Mahé 34
Wuhan 34
Biên Hòa 33
Council Bluffs 33
Düsseldorf 31
Totale 37.644
Salva come PNG Salva come JPEG
Nome #
Access to and quality of elective care: a prospective cohort study using hernia surgery as a tracer condition in 83 countries 1.273
Colorectal Cancer Stage at Diagnosis Before vs During the COVID-19 Pandemic in Italy 432
Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case–control analysis 371
Appraisal of disease-specific benefits of minimally invasiveness in surgery of breast cancer liver metastases 311
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 277
A comprehensive analysis on expected years of life lost due to pancreatic cancer 273
Extracorporeal interval support for organ retrieval delivery regional experience with sharing equipe, equipment & expertise to increase conventionally defined as controlled donor pool in time of pandemic 270
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 268
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 260
Prognostic criteria for postoperative mortality in 170 patients undergoing major right hepatectomy 258
Infected pancreatic necrosis: outcomes and clinical predictors of mortality. A post hoc analysis of the MANCTRA-1 international study 250
Association between multimorbidity and postoperative mortality in patients undergoing major surgery: a prospective study in 29 countries across Europe 243
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 241
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis. 239
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 233
A new liver transplant priority for patients with hepatocellular carcinoma. 232
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array 227
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 227
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 225
[Angiogenic factors and their relation to stage, lymph-node micrometastases and prognosis in patients operated on for gastric cancer] 224
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 222
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 218
Surgical therapy for hepatolithiasis: a Western experience. 215
Characterization of pancreatic ductal adenocarcinoma patients using whole-transcriptome sequencing and copy number analysis by SNPs array techniques. 212
Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. 211
Anticorpi anti-HLA preformati e Trapianto Combinato Rene-Fegato. Caso clinico. 209
Resection line involvement after gastric cancer treatment: handle with care 198
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 198
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis 197
Combined kidney-liver, heart-liver, and kidney-pancreas transplantations from a single deceased donor. 197
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 195
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 195
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 194
Combined liver–dual kidney transplant: Role in expanded donors 193
Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. 191
Clinical Target Volume in Biliary Carcinoma: A Systematic Review of Pathological Studies. 191
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 191
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 191
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 190
Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pre-transplant Radiology 189
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 188
Coping strategies in intestinal transplantation 188
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 187
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. 186
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. 186
Abdominal wall defect repair with biological prosthesis in transplanted patients: single center retrospective analysis and review of the literature 186
Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study 185
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 185
Monofocal hepatocellular carcinoma: How much does size matter? 185
The role of lymphadenectomy for liver tumors. Further considerations on the appropriateness of treatment strategy 183
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 183
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 183
Anatomic variations of intrahepatic bile ducts in a European series and meta-analysis of the literature. 183
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 181
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST) 180
Efficacy of MELD score in predicting survival after liver retransplantation. 177
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients. 177
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 176
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 176
A prospective comparative study between celsior and university of Wisconsin preserving solution in liver transplantation from elderly donors 176
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 176
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience 174
Using Elderly Donors in Liver Transplantation. 173
Combined heart-liver transplantation: A single-center experience 172
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin 172
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST) 171
A prospective multi-center randomized clinical study to compare the efficacy of ertapenem 3 days versus ampicillin-sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection 170
Combined Liver-Kidney Transplantation With Preformed Anti-HLA Antibodies: A Case Report. 170
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. 169
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. 169
Importance of primary indication and liver function between stages: Results of a multicenter Italian audit of ALPPS 2012-2014 169
In Reply 169
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 169
GOSAFE - Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery: early analysis on 977 patients 169
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 169
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 167
Molecular monitoring of organ recipients from cancer-affected donors by detection of circulating tumor cells. 166
Implementation of a patient blood management in an Italian City Hospital: is it effective in reducing the use of red blood cells? 165
Discovery of new potentially actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 165
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 165
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study 165
Years of Life Lost for Older Patients After Colorectal Cancer Diagnosis 164
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 163
Metabolic disorders across hepatocellular carcinoma in Italy 162
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice 161
Gastric splenosis mimicking a gastrointestinal stromal tumor: A case report 161
EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones 161
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma 160
Kidney transplantation combined with other organs in bologna: an update. 160
Age and equity in liver transplantation: An organ allocation model. 160
Incidence, clinical significance, and outcome of vascular alterations in intestinal biopsies after isolated small bowel transplantation: a single-center experience. 159
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 159
Discovery of new potential actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 158
Induction therapy with Alemtuzumab (Campath) in combined liver-kidney transplantation: University of Bologna experience. 158
Incidence and management of abdominal closure-related complications in adult intestinal transplantation. 158
Pattern of macrovascular invasion in hepatocellular carcinoma 158
Ruolo della linfadenectomia in corso di epatectomia per metastasi colorettali. 157
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. 157
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. 156
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? 156
Totale 20.564
Salva come PNG Salva come JPEG
Categoria #
all - tutte 171.820
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 171.820
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.668 0 0 0 0 0 191 193 271 466 271 242 2.034
2021/20227.207 652 273 373 523 638 331 163 539 365 370 1.889 1.091
2022/20237.795 724 1.095 419 913 525 590 252 491 1.364 240 735 447
2023/20242.478 192 392 170 269 208 423 148 182 100 169 120 105
2024/202511.831 462 1.521 967 924 1.878 694 857 438 344 772 613 2.361
2025/202612.213 2.057 2.384 2.400 1.871 2.797 704 0 0 0 0 0 0
Totale 58.968